Background: Incidence of cardiovascular events is increased to two to four times among diabetic patients when compared with non-diabetic. Dyslipidaemia in diabetes is major risk factor for cardiovascular events. Atherogenic indices have been used as major laboratory measures in clinical practice to assess cardiovascular risk. Recent studies, have shown that non-high-density lipoprotein cholesterol and other atherogenic indices is like or better than LDL-C alone in the prediction of CVD incidence and mortality. Aim and Objectives: The aim of this study is to assess the lipid abnormalities with cardiovascular risk using atherogenic coefficient (Ac), Cardiac Risk Ratio (TC/HDLc and LDLc/HDLc), TG/HDLc and Non-HDL in diabetes patients. Materials and Methods: A cross-sectional descriptive study conducted at Bir hospital (tertiary care center) Nepal. Patients diagnosed as diabetes with age 30 years or above were selected in this study during a period of 1 yr. Results: The mean age of the patients enrolled was 55. 08±1.11 (34-81) year with male (52 %) to female (48%) ratio is 1.08:1. In this study the mean Non HDLc was 165.24±43.40 mg/dl (65-323) and AC was 4.0±1.09. The finding of AC was slightly higher in female compare to male i.e mean ±S.D 4.07±1.31 and 3.94±1.15. This study show the strong correlation of Non HDLc with total cholesterol (r=.990, p=0.000), LDLc(r=.602,p=0.000),TG (r=.411,p=0.000), LDLc/HDLc (r=.580,p=0.000),TC/HDLc ((r=.866,p=0.000), TG/HDLc (r=.390,p=0.000) and AC (p=0.866). Conclusion: The association between abnormal lipid levels and cardiovascular risk is evident among patients with diabetes mellitus. In this study there is the correlation with FBS, Non HDL-c cholesterol, Cardio risk ratio, TG/HDLc, Atherogenic coefficient. Hence Non-HDL cholesterol and Atherogenic indices proves to be more sensitive and a better predictor of cardiovascular events in diabetes patients.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disease resulting from insulin deficiency and/or insulin resistance. It is one of the leading causes of death worldwide. Incidence of cardiovascular events is increased to two to four times among diabetic patients when compared with non-diabetic. About 78% percent of type 2 diabetic patients succumb to death from due to premature atherosclerosis which involves dyslipidemia, 1, 2, 3 The cardiovascular diseases (CVD) risk of DM increases further if it is associated with dyslipidemia. Dyslipidemia in diabetes is characterized by elevated triglyceride (TG), low levels of high density lipoprotein cholesterol (HDL-C) and increased prevalence of small dense low density lipoprotein Assessment of lipid abnormalities and cardiovascular risk indices in type 2 diabetes mellitus cholesterol (LDL-C) particles. Serum total cholesterol (TC) and LDL-C have been used as major laboratory measures in clinical practice to assess cardiovascular risk. Recent studies, however, have shown that non-high density lipoprotein cholesterol (non-HDL-C) concentration is similar to or better than LDL-C alone in the prediction of CVD incidence and mortality. 3 Evaluating CVD risk measures include the use of atherogenic indices which are less expensive and noninvasive techniques. 4 In predicting CVD risk especially when absolute values of lipid parameters are not markedly deranged atherogenic indices contribute significantly. 5,6 Atherogenic indices considered in this study include TG/HDL ratio, Non-High-density lipoprotein cholesterol (NHDL-C), Atherogenic coefficient (AC), Castelli risk index 1 (CRI-1) and Castelli risk index 2 (CRI-2).
CRI-1 and CRI-2 were calculated as TC/HDL-C and LDL-C/HDLC respectively as described by Koleva et al. 7 Non HDL-C was calculated as TC -HDL-C as described by Devadawson 8 et al while AC was calculated as TC -HDL-C)/HDL-C as described by Brehm et al 9 . Castelli risk index (CRI) is also used as a predictor of CVD risks and it is based on lipid parameters i.e: TG, LDL-C and HDL-C which are in turn independent risk factors for CVD. 9 CRI-1 and CRI-2 are more sensitive and specific indices of CVD risk than TC, LDL-C and particularly in individuals with hypertriglyceridemia of >300 mg/dl. CRI-1 is also known as cardiac risk ratio (CRR). It is defined as the ratio of total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C). CRI-2 is a molar ratio, defined as the ratio of low density lipoprotein (LDL-C) to high density lipoprotein (HDL-C). 10 CRI-1 and CRI-2 were observed to be high in individuals with metabolic syndrome when compared with healthy individuals, thus was reported to be indicative of risk to CVD. A CRI-1 value ≤3.5 is seen as normal while a value >3.5 indicates a high risk of CVD. A CRI-2 value ≤3.0 is normal while ≥3.0 is indicative of CVD risk. 7, 11 Triglyceride/HDL-C ratio predicts CHD and CVD mortality, A TG/HDL-C ratio of 3.5 or greater to be highly correlated with insulin resistance and atherogenic dyslipidemia in men; this threshold was also associated with metabolic syndrome. They proposed that the TG/HDL-C ratio provides a simple way to identify insulin-resistant, dyslipidemic patients who are likely to be at increased risk for CVD. [12] [13] [14] Therefore, the aim of this study is to assess the lipid abnormalities with cardiovascular risk using atherogenic coefficient (Ac), Cardiac Risk Ratio (TC/HDLc and LDLc/HDLc), TG/HDLc and Non-HDL in diabetes patients.
MATERIALS AND METHODS
This was a hospital based cross-sectional descriptive study conducted at Bir hospital, Nepal. Patients diagnosed as diabetes with age 30 years or above were selected in this study during a period of 1 yr. Blood sample was taken from the patients admitted and the patient attending outpatient department center at Bir hospital.
Diagnosis of DM:
Diabetes is defined as per the guidelines of ADA.
Inclusion criteria
Patients with glycated hemoglobin level of ≥6.5 % or fasting plasma glucose of ≥126 mg/dl (7.0 mmol/l) or 2-hour post-load glucose ≥200 mg/dl (11.1 mmol/L) during an OGTT were recruited as a research participants. However, the research participants had to further fulfil two more criteria: • Patients with age ≥30 years • Sex-male or female • Diagnosed patients of diabetes ≥3 years and under oral anti-diabetic agents and/or insulin or under dietary controls.
Exclusion criteria
• Diabetic patients with age below 30 years • Diabetic patients with duration of less than 3 years • Patients with known diagnosis of type-1 DM
Data collection
Blood sampling was taken for patients admitted and attending (outpatient) in our Center (Bir Hospital). This was done with clinical and biochemical evidence during the study period after obtaining informed consent.
Data was collected using a structured Proforma covering the relevant details. Patients fulfilling the inclusion criteria were explained about the nature of the study and informed written consent was obtained from those willing to get enrolled.
Laboratory analysis
Blood Glucose: Determination of blood glucose was done by glucose oxidase method.
HbA1c: It was measured by Nycocard kit reader method.
Uric acid: Serum uric acid was measured by uricase method.
Triglyceride: Serum triglyceride was estimated by Fossati and Prencipe method associated with Trinder reaction.
Total Cholesterol: Total cholesterol was estimated by enzymatic method.
HDL-C: The chylomicrons, VLDL-C and LDL-C was precipitated by addition of phosphotungstic acid and magnesium chloride. After centrifugation the supernatant fluid contains the HDL (high density lipoproteins) fraction, which was assayed for cholesterol as described above. 
RESULTS
Total 125 patients with diagnosis of type 2 Diabetes mellitus were enrolled in the study. The enrolled patients met the inclusion criteria and they were either from OPD or admitted at wards of Bir Hospital. The mean age of the patients enrolled was 55.08±1. 11 (34-81) year with male (52 %) to female (48%) ratio is 1.08:1 The highest numbers of the patients were found to be in the age ranges from 40 to 50. (Figures 1 and 2) . Table 1 shows the difference between male and female in various biochemical parameter in which the mean Fasting Blood Sugar and total cholesterol was higher in female compare to male.
In this study, desirable cholesterol was 44% with borderline and very high risk was 29.6% and 26.4% respectively. Similarly, 33.6 % had normal LDL level and near optimal, borderline and high risk was 44 %,16% and 5.6%. In this study 36% of patients had decreased HDLc level and TG was elevated in 68.8% as in Table 2 . Table 3 shows the cardiovascular risk indices difference between male and female diabetes patients in which AC,TG/ HDL,TC/HDLc are higher in female diabetes patients.
The study showed that AC and CRI-1 was high in 80%,CRI-2 and TG/HDLc was increased in 23.2% and 78.6% respectively ( Table 4 ) High significant correlation was observed between Atherogenic indices as shown in Table 5 . This shows that there was association between cardiovascular risk indices in diabetes patient.
DISCUSSION
It is well known that diabetes patients have a high incidence of CVD. The pathogenesis of CVD in diabetes is multifactorial and among them dyslipidemia is found to be a powerful risk factor along with Atherogenic indices.
In this study, 125 patients of diabetes with 3 years or more duration were included and assessment of lipid abnormalities and Cardiovascular Risk were observed. Diagnosed cases of type 2 diabetes aged between 34 to 81 years were taken in the study. In this study the mean age was 55.08±1.11 (34-81) year with male (52 %) to female (48%) ratio of 1 This study showed that 42.6% of the patients enrolled into the study had normal fasting lipid profile. The cutoff values for dyslipidemia were those not falling into the desirable range as per ADA criteria or use of lipid lowering agents. As per this value total cholesterol <200 mg/dl, TG <150 mg/dl, LDL <100mg/dl and HDL >40 mg/dl for males and >50 mg/dl for females were taken normal values.
The lipid values above those were considered dyslipidemia.
Taking these reference ranges the prevalence of dyslipidemia in this study was 57.4%. Among the individual lipid levels total cholesterol was normal in 44% and increased in 56% of patients. Similarly, the LDL levels were normal in 33.6% and increased in 66.4%. HDL on the other hand was normal in 64 % and decreased 36% of subjects. Lastly TG levels were normal in 31.2% and deranged in 68.8%.
T h e m e a n t o t a l c h o l e s t e r o l , L D L c, H D L c and TG in our study was 207. 44±43.62 mg/ dl, 20 and Jayarama N et al study. 21 Samatha P et al concluded that the diabetic patients had a higher prevalence of high serum cholesterol, high triacylglycerol and high ldl-c than the controls, indicating that diabetic patients were more prone to cardiovascular diseases. Bodhe C et al 23 reported that several lipoprotein-related indices plasma concentrations of lipids (LDL-C, HDL-C, and TGs), molar ratios (TG/HDLC and LDL-C/HDL-C), and particle size (LDL and HDL)] have been used to predict CHD risk. The total cholesterol/HDL-C and LDL-C/HDL-C molar ratios have good predictive value for future cardiovascular events. 
